Audiovestibular evolution in a patient with multiple sclerosis.
Tu
Chuan-En
CE
Department of Otolaryngology, Buddhist Tzu Chi General Hospital, Hualien.
Young
Yi-Ho
YH
D000328:Adult; D001933:Brain Stem / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000473:pathology / Q000503:physiopathology; D004292:Dominance, Cerebral / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004584:Electronystagmography / Q000187:drug effects; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects / Q000502:physiology*; D005260:Female; D020546:Fourth Ventricle / Q000473:pathology / Q000503:physiopathology; D006312:Hearing Loss, Bilateral / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006316:Hearing Loss, High-Frequency / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D011239:Prednisolone / Q000008:administration & dosage; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D014724:Vestibular Function Tests; D014725:Vestibular Nerve / Q000187:drug effects / Q000503:physiopathology; D020338:Vestibular Neuronitis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology
D011239:Prednisolone